APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade Sodium Hyaluronate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade Sodium Hyaluronate Market Outlook and Growth Opportunities 2026

10 April 2026Not stated

Choose your research edition.

Industry ResearchPharmaceutical Grade Sodium Hyaluronate Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade Sodium Hyaluronate Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade Sodium Hyaluronate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade Sodium Hyaluronate Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade Sodium Hyaluronate Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade Sodium Hyaluronate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade Sodium Hyaluronate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade Sodium Hyaluronate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade Sodium Hyaluronate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade Sodium Hyaluronate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade Sodium Hyaluronate market include Shan dong liyoung biotechnology co.,Ltd, Biotechnology Corp.,Ltd., NovaMatrix, Lifecore Biomedical, Inc., Kikkoman Corporation, Kewpie and Contipro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade Sodium Hyaluronate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade Sodium Hyaluronate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade Sodium Hyaluronate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Sodium Hyaluronate market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade Sodium Hyaluronate Segment by Company

Shan dong liyoung biotechnology co.,Ltd

Biotechnology Corp.,Ltd.

NovaMatrix

Lifecore Biomedical, Inc.

Kikkoman Corporation

Kewpie

Contipro

Pharmaceutical Grade Sodium Hyaluronate Segment by Type

High Molecular Weight Sodium Hyaluronate

Low Molecular Weight Sodium Hyaluronate

Pharmaceutical Grade Sodium Hyaluronate Segment by Application

Injections

Eye Drops

External Preparations

Others

Pharmaceutical Grade Sodium Hyaluronate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Grade Sodium Hyaluronate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade Sodium Hyaluronate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade Sodium Hyaluronate significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade Sodium Hyaluronate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Sodium Hyaluronate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Sodium Hyaluronate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Sodium Hyaluronate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Sodium Hyaluronate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Sodium Hyaluronate industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade Sodium Hyaluronate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade Sodium Hyaluronate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade Sodium Hyaluronate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade Sodium Hyaluronate Industry Trends Table 2. Pharmaceutical Grade Sodium Hyaluronate Industry Drivers Table 3. Pharmaceutical Grade Sodium Hyaluronate Industry Opportunities and Challenges Table 4. Pharmaceutical Grade Sodium Hyaluronate Industry Restraints Table 5. Global Pharmaceutical Grade Sodium Hyaluronate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade Sodium Hyaluronate Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Company (t) & (2021-2026) Table 8. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade Sodium Hyaluronate Average Price (USD/kg) of Company (2021-2026) Table 10. Global Pharmaceutical Grade Sodium Hyaluronate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade Sodium Hyaluronate Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade Sodium Hyaluronate Company, Product Type & Application Table 13. Global Pharmaceutical Grade Sodium Hyaluronate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade Sodium Hyaluronate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of High Molecular Weight Sodium Hyaluronate Table 18. Significant Companies of Low Molecular Weight Sodium Hyaluronate Table 19. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type (2021-2026) & (t) Table 21. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type (2027-2032) & (t) Table 22. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Type (2021-2026) Table 23. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Type (2027-2032) Table 24. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type (2021-2026) Table 28. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injections Table 30. Significant Companies of Eye Drops Table 31. Significant Companies of External Preparations Table 32. Significant Companies of Others Table 33. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application (2021-2026) & (t) Table 35. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application (2027-2032) & (t) Table 36. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Application (2021-2026) Table 37. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Application (2027-2032) Table 38. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application (2021-2026) Table 42. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application (2027-2032) Table 43. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region (2021-2026) & (t) Table 45. Global Pharmaceutical Grade Sodium Hyaluronate Sales Market Share by Region (2021-2026) Table 46. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region (2027-2032) & (t) Table 47. Global Pharmaceutical Grade Sodium Hyaluronate Sales Market Share by Region (2027-2032) Table 48. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Region (2021-2026) Table 51. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Region (2027-2032) Table 53. Global Pharmaceutical Grade Sodium Hyaluronate Market Average Price (USD/kg) by Region (2021-2026) Table 54. Global Pharmaceutical Grade Sodium Hyaluronate Market Average Price (USD/kg) by Region (2027-2032) Table 55. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country (2021-2026) & (t) Table 58. Global Pharmaceutical Grade Sodium Hyaluronate Sales Market Share by Country (2021-2026) Table 59. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country (2027-2032) & (t) Table 60. Global Pharmaceutical Grade Sodium Hyaluronate Sales Market Share by Country (2027-2032) Table 61. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Market Share by Country (2021-2026) Table 63. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Market Share by Country (2027-2032) Table 65. Shan dong liyoung biotechnology co.,Ltd Company Information Table 66. Shan dong liyoung biotechnology co.,Ltd Business Overview Table 67. Shan dong liyoung biotechnology co.,Ltd Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 68. Shan dong liyoung biotechnology co.,Ltd Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 69. Shan dong liyoung biotechnology co.,Ltd Recent Development Table 70. Biotechnology Corp.,Ltd. Company Information Table 71. Biotechnology Corp.,Ltd. Business Overview Table 72. Biotechnology Corp.,Ltd. Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 73. Biotechnology Corp.,Ltd. Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 74. Biotechnology Corp.,Ltd. Recent Development Table 75. NovaMatrix Company Information Table 76. NovaMatrix Business Overview Table 77. NovaMatrix Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 78. NovaMatrix Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 79. NovaMatrix Recent Development Table 80. Lifecore Biomedical, Inc. Company Information Table 81. Lifecore Biomedical, Inc. Business Overview Table 82. Lifecore Biomedical, Inc. Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 83. Lifecore Biomedical, Inc. Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 84. Lifecore Biomedical, Inc. Recent Development Table 85. Kikkoman Corporation Company Information Table 86. Kikkoman Corporation Business Overview Table 87. Kikkoman Corporation Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 88. Kikkoman Corporation Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 89. Kikkoman Corporation Recent Development Table 90. Kewpie Company Information Table 91. Kewpie Business Overview Table 92. Kewpie Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 93. Kewpie Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 94. Kewpie Recent Development Table 95. Contipro Company Information Table 96. Contipro Business Overview Table 97. Contipro Pharmaceutical Grade Sodium Hyaluronate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 98. Contipro Pharmaceutical Grade Sodium Hyaluronate Product Portfolio Table 99. Contipro Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Pharmaceutical Grade Sodium Hyaluronate Distributors List Table 103. Pharmaceutical Grade Sodium Hyaluronate Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Pharmaceutical Grade Sodium Hyaluronate Product Image Figure 2. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade Sodium Hyaluronate Sales (2021-2032) & (t) Figure 5. Global Pharmaceutical Grade Sodium Hyaluronate Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Pharmaceutical Grade Sodium Hyaluronate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. High Molecular Weight Sodium Hyaluronate Image Figure 10. Low Molecular Weight Sodium Hyaluronate Image Figure 11. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Type (2021-2032) Figure 14. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type (2021-2032) Figure 17. Injections Image Figure 18. Eye Drops Image Figure 19. External Preparations Image Figure 20. Others Image Figure 21. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Application (2021-2032) Figure 24. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application (2021-2032) Figure 27. Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Pharmaceutical Grade Sodium Hyaluronate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pharmaceutical Grade Sodium Hyaluronate Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pharmaceutical Grade Sodium Hyaluronate Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • High Molecular Weight Sodium Hyaluronate
  • Low Molecular Weight Sodium Hyaluronate
Applications
  • Injections
  • Eye Drops
  • External Preparations
  • Others
Companies covered
  • Shan dong liyoung biotechnology co.,Ltd
  • Biotechnology Corp.,Ltd.
  • NovaMatrix
  • Lifecore Biomedical, Inc.
  • Kikkoman Corporation
  • Kewpie
  • Contipro

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade Sodium Hyaluronate Market Dynamics
  1. 2.1 Pharmaceutical Grade Sodium Hyaluronate Industry Trends
  2. 2.2 Pharmaceutical Grade Sodium Hyaluronate Industry Drivers
  3. 2.3 Pharmaceutical Grade Sodium Hyaluronate Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade Sodium Hyaluronate Industry Restraints
3 Pharmaceutical Grade Sodium Hyaluronate Market by Company
  1. 3.1 Global Pharmaceutical Grade Sodium Hyaluronate Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade Sodium Hyaluronate Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade Sodium Hyaluronate Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade Sodium Hyaluronate Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade Sodium Hyaluronate Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade Sodium Hyaluronate Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade Sodium Hyaluronate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade Sodium Hyaluronate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade Sodium Hyaluronate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade Sodium Hyaluronate Market by Type
  1. 4.1 Pharmaceutical Grade Sodium Hyaluronate Type Introduction
  2. 4.1.1 High Molecular Weight Sodium Hyaluronate
  3. 4.1.2 Low Molecular Weight Sodium Hyaluronate
  4. 4.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type
  5. 4.2.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type
  9. 4.3.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade Sodium Hyaluronate Market by Application
  1. 5.1 Pharmaceutical Grade Sodium Hyaluronate Application Introduction
  2. 5.1.1 Injections
  3. 5.1.2 Eye Drops
  4. 5.1.3 External Preparations
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application
  7. 5.2.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application
  11. 5.3.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade Sodium Hyaluronate Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade Sodium Hyaluronate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade Sodium Hyaluronate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade Sodium Hyaluronate Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade Sodium Hyaluronate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade Sodium Hyaluronate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shan dong liyoung biotechnology co.,Ltd
  2. 8.1.1 Shan dong liyoung biotechnology co.,Ltd Company Information
  3. 8.1.2 Shan dong liyoung biotechnology co.,Ltd Business Overview
  4. 8.1.3 Shan dong liyoung biotechnology co.,Ltd Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shan dong liyoung biotechnology co.,Ltd Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  6. 8.1.5 Shan dong liyoung biotechnology co.,Ltd Recent Developments
  7. 8.2 Biotechnology Corp.,Ltd.
  8. 8.2.1 Biotechnology Corp.,Ltd. Company Information
  9. 8.2.2 Biotechnology Corp.,Ltd. Business Overview
  10. 8.2.3 Biotechnology Corp.,Ltd. Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biotechnology Corp.,Ltd. Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  12. 8.2.5 Biotechnology Corp.,Ltd. Recent Developments
  13. 8.3 NovaMatrix
  14. 8.3.1 NovaMatrix Company Information
  15. 8.3.2 NovaMatrix Business Overview
  16. 8.3.3 NovaMatrix Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NovaMatrix Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  18. 8.3.5 NovaMatrix Recent Developments
  19. 8.4 Lifecore Biomedical, Inc.
  20. 8.4.1 Lifecore Biomedical, Inc. Company Information
  21. 8.4.2 Lifecore Biomedical, Inc. Business Overview
  22. 8.4.3 Lifecore Biomedical, Inc. Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lifecore Biomedical, Inc. Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  24. 8.4.5 Lifecore Biomedical, Inc. Recent Developments
  25. 8.5 Kikkoman Corporation
  26. 8.5.1 Kikkoman Corporation Company Information
  27. 8.5.2 Kikkoman Corporation Business Overview
  28. 8.5.3 Kikkoman Corporation Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kikkoman Corporation Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  30. 8.5.5 Kikkoman Corporation Recent Developments
  31. 8.6 Kewpie
  32. 8.6.1 Kewpie Company Information
  33. 8.6.2 Kewpie Business Overview
  34. 8.6.3 Kewpie Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kewpie Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  36. 8.6.5 Kewpie Recent Developments
  37. 8.7 Contipro
  38. 8.7.1 Contipro Company Information
  39. 8.7.2 Contipro Business Overview
  40. 8.7.3 Contipro Pharmaceutical Grade Sodium Hyaluronate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Contipro Pharmaceutical Grade Sodium Hyaluronate Product Portfolio
  42. 8.7.5 Contipro Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade Sodium Hyaluronate Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade Sodium Hyaluronate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade Sodium Hyaluronate Sales Mode & Process
  6. 9.2 Pharmaceutical Grade Sodium Hyaluronate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade Sodium Hyaluronate Distributors
  9. 9.2.3 Pharmaceutical Grade Sodium Hyaluronate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst